EMA'S CHMP Says No Need for Separate Mounjaro Indication for OSA in Obese Adults

T-Reuters12-13

Dec 13 (Reuters) - Ema'S Chmp: :Ema'S Chmp: Finalised Assessment Of Application To Extend Use Of Mounjaro To Include Treatment Of Obstructive Sleep Apnoea In Adults With Obesity.Ema'S Chmp: Separate Indication For Treatment Of Moderate To Severe Osa In Adults With Obesity Is Not Needed For Mounjaro.Ema'S Chmp: Adopted Positive Opinion For Beyonttra (Acoramidis).Ema'S Chmp: Kavigale (Sipavibart) Received Positive Opinion.Ema'S Chmp: Rytelo Gets Positive Opinion For Treatment Of Adults With Transfusion-Dependent Anaemia.Ema'S Chmp: Recommended Granting Conditional Marketing Authorisation For Welireg (Belzutifan).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2491320211?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-13 19:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2491320211","market":"sh","top_or_hot":-1,"title":"EMA'S CHMP Says No Need for Separate Mounjaro Indication for OSA in Obese Adults","media":"T-Reuters","content":"<html><body><p>Dec 13 (Reuters) - Ema'S Chmp: :Ema'S Chmp: Finalised Assessment Of Application To Extend Use Of Mounjaro To Include Treatment Of Obstructive Sleep Apnoea In Adults With Obesity.Ema'S Chmp:  Separate Indication For Treatment Of Moderate To Severe Osa In Adults With Obesity Is Not Needed For Mounjaro.Ema'S Chmp: Adopted Positive Opinion For Beyonttra (Acoramidis).Ema'S Chmp: Kavigale (Sipavibart) Received Positive Opinion.Ema'S Chmp: Rytelo Gets Positive Opinion For Treatment Of Adults With Transfusion-Dependent Anaemia.Ema'S Chmp: Recommended Granting Conditional Marketing Authorisation For Welireg (Belzutifan).</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EMA'S CHMP Says No Need for Separate Mounjaro Indication for OSA in Obese Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEMA'S CHMP Says No Need for Separate Mounjaro Indication for OSA in Obese Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-13 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.trkd.thomsonreuters.com><strong>T-Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dec 13 (Reuters) - Ema'S Chmp: :Ema'S Chmp: Finalised Assessment Of Application To Extend Use Of Mounjaro To Include Treatment Of Obstructive Sleep Apnoea In Adults With Obesity.Ema'S Chmp:  Separate ...</p>\n\n<a href=\"https://www.trkd.thomsonreuters.com\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://www.trkd.thomsonreuters.com","article_id":"2491320211","we_media_id":"1086160438","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2491320211","pubTimestamp":1734090488,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"T-Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"summary":"Dec 13  - Ema'S Chmp: :Ema'S Chmp: Finalised Assessment Of Application To Extend Use Of Mounjaro To Include Treatment Of Obstructive Sleep Apnoea In Adults With Obesity.Ema'S Chmp:  Separate Indication For Treatment Of Moderate To Severe Osa In Adults With Obesity Is Not Needed For Mounjaro.Ema'S Chmp: Adopted Positive Opinion For Beyonttra .Ema'S Chmp: Kavigale  Received Positive Opinion.Ema'S Chmp: Rytelo Gets Positive Opinion For Treatment Of Adults With Transfusion-Dependent Anaemia.Ema'S Chmp: Recommended Granting Conditional Marketing Authorisation For Welireg .","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","LU1829250122.USD":"高盛欧洲核心股票组合Acc","LU2417539215.USD":"ALLIANZ GLOBAL INCOME \"AMF\" (USD) INC","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","BK4568":"美国抗疫概念","BK4588":"碎股","BK4007":"制药","LU2456880835.USD":"ALLIANZ GLOBAL INCOME \"AT\" (USD) ACC","AZN":"阿斯利康","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC","LU2462157665.USD":"ALLIANZ GLOBAL INCOME \"A\" (USD) INC"},"translate_title":"EMA的CHMP表示肥胖成人OSA无需单独使用Mounjaro适应症","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AZN":0.9},"content_text":"Dec 13 (Reuters) - Ema'S Chmp: :Ema'S Chmp: Finalised Assessment Of Application To Extend Use Of Mounjaro To Include Treatment Of Obstructive Sleep Apnoea In Adults With Obesity.Ema'S Chmp:  Separate Indication For Treatment Of Moderate To Severe Osa In Adults With Obesity Is Not Needed For Mounjaro.Ema'S Chmp: Adopted Positive Opinion For Beyonttra (Acoramidis).Ema'S Chmp: Kavigale (Sipavibart) Received Positive Opinion.Ema'S Chmp: Rytelo Gets Positive Opinion For Treatment Of Adults With Transfusion-Dependent Anaemia.Ema'S Chmp: Recommended Granting Conditional Marketing Authorisation For Welireg (Belzutifan).","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2491320211"}